title: [Using meglumine acridonacetate for the treatment of gastroenteritis caused by rotavirus in children].
abstract: The study was aimed at an analysis of the influence of meglumine acridonacetate--the inductor of endogenous interferon synthesis--on the clinical course of gastroenteritis caused by rotavirus in children. A group of 100 patients aged from 3 months to 14 years were involved on retrospective comparative randomized study. The obtained data showed the advantages of meglumine acridonacetate administration during early terms of treatment of the gastroenteritis caused by rotaviruses. This treatment leads to fast regression of the main clinical symptoms such as fever, diarrhea, and intoxications, which results in reduction of the clinical course duration.
authors.forename: E B
authors.initials: EB
authors.lastname: Vasiutenko
authors.forename: A G
authors.initials: AG
authors.lastname: Petrova
mesh_terms: D000166:Acridines / Q000627:therapeutic use*; D001772:Blood Cell Count; D002648:Child; D002675:Child, Preschool; D005260:Female; D005440:Fluid Therapy; D005759:Gastroenteritis / Q000503:physiopathology / Q000628:therapy* / Q000821:virology; D006801:Humans; D007223:Infant; D007369:Interferon Inducers / Q000627:therapeutic use*; D008297:Male; D019936:Probiotics / Q000627:therapeutic use; D012401:Rotavirus / Q000187:drug effects* / Q000254:growth & development; D012400:Rotavirus Infections / Q000503:physiopathology / Q000628:therapy* / Q000821:virology; D016896:Treatment Outcome
chemical_list: D000166:Acridines; D007369:Interferon Inducers; C026430:10-carboxymethyl-9-acridanone